ALTERITY THERAPEUTICS LTD SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADOct 9

   Alterity Therapeutics to present at conference

   • David Stamler to present on Oct 12, 2026
   • Phase 3 trial in MSA upcoming
   • ATH434 shows efficacy in Phase 2 trials
2. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADOct 5

   Alterity Therapeutics reports positive Phase 2 data for ATH434 in MSA

   • ATH434 50 mg slowed functional decline by 52% vs. placebo in MSA
   • CSF NfL predicted functional decline and was used as a covariate
   • MRI showed iron redistribution in MSA patients treated with ATH434
3. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 25

   Foreign issuer report

4. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 23

   Foreign issuer report

5. ROUTINES-8ALTERITY THERAPEUTICS LTDPRNADSep 18

   Employee stock plan registration

6. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 18

   Foreign issuer report

7. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 16

   Foreign issuer report

8. ROUTINE4ALTERITY THERAPEUTICS LTDPRNADSep 8

   2 insider filings

   Peter Ashley Marks, insider filing for PRNAD

   Show all 2

   • 4Insider filing for PRNADSep 8
   • 4Insider filing for PRNADSep 8

   Peter Ashley Marks, reporting

9. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 8

   Foreign issuer report

10. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 8

    Foreign issuer report

11. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 3

    Foreign issuer report

12. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 2

    Foreign issuer report

13. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 2

    Foreign issuer report

14. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADSep 1

    Foreign issuer report

15. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 31

    Foreign issuer report

16. NOTABLE20-FALTERITY THERAPEUTICS LTDPRNADAug 28

    Annual report

17. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 28

    Foreign issuer report

18. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 28

    Foreign issuer report

19. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 28

    Foreign issuer report

20. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 21

    Foreign issuer report

21. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 17

    Foreign issuer report

22. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 14

    Foreign issuer report

23. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 13

    Foreign issuer report

24. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 10

    Foreign issuer report

25. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 6

    Foreign issuer report

26. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADAug 4

    Foreign issuer report

27. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 30

    Foreign issuer report

28. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 29

    Foreign issuer report

29. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 28

    Foreign issuer report

30. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 21

    Foreign issuer report

31. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 21

    Foreign issuer report

32. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 9

    Foreign issuer report

33. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 9

    Foreign issuer report

34. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 7

    Foreign issuer report

35. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJul 1

    Foreign issuer report

36. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 30

    Foreign issuer report

37. ROUTINE4ALTERITY THERAPEUTICS LTDPRNADJun 23

    2 insider filings

    Julian Michael Babarczy, insider filing for PRNAD

    Show all 2

    • 4Insider filing for PRNADJun 23
    • 4Insider filing for PRNADJun 23

    Julian Michael Babarczy, reporting

38. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 17

    Foreign issuer report

39. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 16

    Foreign issuer report

40. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 15

    Foreign issuer report

41. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 15

    Foreign issuer report

42. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNADJun 12

    Foreign issuer report

43. ROUTINE6-KALTERITY THERAPEUTICS LTDATHEJun 9

    Foreign issuer report

44. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNAFJun 4

    Foreign issuer report

45. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNAFJun 3

    Foreign issuer report

46. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNAFMay 29

    Foreign issuer report

47. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNAFMay 19

    Foreign issuer report

48. ROUTINE6-KALTERITY THERAPEUTICS LTDPRNAFMay 12

    Foreign issuer report

Older filings on EDGAR